Challenges and opportunities in developing respiratory syncytial virus therapeutics.

J Infect Dis · 2015 · PMC4345819 · PMID 25713060

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Another recent study of 181 HSCT recipients with RSV URTI showed a trend toward less frequent progression to LRTI with aerosolized ribavirin [ 47 ].

also in 53,322 other papers

did not reach statistical significanceno p-value reported

There was a higher probability of RSV RNA detection in serum samples from patients with higher viral load in bronchioalveloar lavage, but the effect did not reach statistical significance [ 42 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.